Log in to save to my catalogue

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic targe...

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic targe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_871003761

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

About this item

Full title

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2011-06, Vol.17 (6), p.715-719

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

This report identifies LMTK3 kinase as a regulator of ERα activity. LMTK3 exerts its effects through direct interaction and indirectly through regulation of PKC, AKT and FOXO3's effects on ERα transcription and stability. LMTK3 can modulate tamoxifen responses and is a poor prognostic factor in human breast cancer.
Therapies targeting estrogen r...

Alternative Titles

Full title

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_871003761

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_871003761

Other Identifiers

ISSN

1078-8956,1546-170X

E-ISSN

1546-170X

DOI

10.1038/nm.2351

How to access this item